Evidity Health Capital is a late-stage venture capital and growth equity firm that focuses on the healthcare sector, specifically targeting medical devices, in vitro diagnostics, and disruptive digital health. The firm invests in private companies with commercialized products that require growth capital to reach profitability. Evidity Health Capital typically participates in Series A through Series D funding rounds, providing the necessary resources to scale innovative healthcare solutions.
Notable portfolio companies include Augmedics, EndoGastric Solutions, Magnolia Medical Technologies, Sonde Health, and Tryton Medical. The firm is led by a cohesive team of three investment partners who bring diverse and complementary expertise to the table. Evidity Health Capital prides itself on being value-focused and evidence-based, offering business-building support to its portfolio companies. This hands-on approach helps ensure that the companies they invest in can achieve sustainable growth and success in the competitive healthcare market.
Evidity Health Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Top Investment Stages
Evidity Health Capital: A healthcare VC firm specializing in funding growth for innovative medical and digital health companies.
Stage Mix
Concentration shown as share of disclosed investments by stage.
Revival Healthcare Capital
rvlhc.com
HealthTrend Capital
healthtrendcap.com
Health2047 Capital Partners
InnovaHealth Partners
HealthEdge Investment Partners
Signet Healthcare Partners
EGS Healthcare Capital Partners
Evidenced
evidenced.com
Health Catalyst Capital
Regal Healthcare Capital Partners
regalhcp.com
HealthQuest Capital
Enhanced Healthcare Partners
NaviMed Capital Advisors
navimed.com
Petrichor Healthcare Capital Management
petrichorcap.com
Ambit Health Ventures
